Cargando…
Peripheral Cannabinoid-1 Receptor Blockade Ameliorates Cystitis Severity
BACKGROUND: The endocannabinoid system (ECS) plays a key physiological role in bladder function and it has been suggested as a potential target for relieving lower urinary tract symptoms (LUTSs). Whereas most studies indicate that activating the ECS has some beneficial effects on the bladder, some s...
Autores principales: | Hinden, Liad, Ludyansky, Rami, Leidershnaider, Sary, Harris, Yoav, Nemirovski, Alina, Gofrit, Ofer N., Tam, Joseph, Hidas, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442677/ https://www.ncbi.nlm.nih.gov/pubmed/35647939 http://dx.doi.org/10.1089/can.2022.0077 |
Ejemplares similares
-
Systemic Changes in Endocannabinoids and Endocannabinoid-like Molecules in Response to Partial Nephrectomy-Induced Ischemia in Humans
por: Rothner, Ariel, et al.
Publicado: (2023) -
Kidney Proximal Tubule GLUT2—More than Meets the Eye
por: Ahmad, Majdoleen, et al.
Publicado: (2022) -
Hepatic targeting of the centrally active cannabinoid 1 receptor (CB(1)R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes
por: Hirsch, Shira, et al.
Publicado: (2023) -
CB(1)R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance
por: Drori, Adi, et al.
Publicado: (2020) -
A Novel Indoline Derivative Ameliorates Diabesity-Induced Chronic Kidney Disease by Reducing Metabolic Abnormalities
por: Permyakova, Anna, et al.
Publicado: (2020)